tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Financial Statements

Compare
407 Followers

PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently $6.21B. The company's EPS TTM is $0.2; its P/E ratio is 9.03; PTC Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 806.78M$ 937.82M$ 698.80M$ 538.59M$ 380.77M
Gross Profit$ 749.38M$ 872.34M$ 654.12M$ 506.26M$ 361.82M
Operating Income$ -302.57M$ -439.50M$ -447.41M$ -374.44M$ -431.77M
EBITDA$ -120.46M$ -330.34M$ -367.78M$ -368.18M$ -303.09M
Net Income$ -363.30M$ -626.60M$ -559.02M$ -523.90M$ -438.16M
Balance Sheet
Cash & Short-Term Investments$ 1.14B$ 876.74M$ 410.70M$ 773.38M$ 1.10B
Total Assets$ 1.71B$ 1.90B$ 1.71B$ 1.94B$ 2.21B
Total Debt$ 2.47B$ 2.23B$ 1.46B$ 1.27B$ 420.44M
Net Debt$ 1.69B$ 1.64B$ 1.18B$ 1.08B$ 211.63M
Total Liabilities$ 2.80B$ 2.71B$ 2.05B$ 1.94B$ 1.73B
Stockholders' Equity$ -1.10B$ -818.55M$ -347.09M$ 1.44M$ 481.98M
Cash Flow
Free Cash Flow$ -181.94M$ -279.04M$ -509.11M$ -336.66M$ -250.05M
Operating Cash Flow$ -107.69M$ -158.42M$ -356.65M$ -251.33M$ -194.07M
Investing Cash Flow$ 44.18M$ -176.74M$ 290.18M$ 219.18M$ -561.55M
Financing Cash Flow$ 255.87M$ 646.40M$ 167.95M$ 20.88M$ 668.72M
Currency in USD

PTC Therapeutics Earnings and Revenue History

PTC Therapeutics Debt to Assets

PTC Therapeutics Cash Flow

PTC Therapeutics Forecast EPS vs Actual EPS